Alliancebernstein L.P. lifted its holdings in shares of Tempus AI, Inc. (NASDAQ:TEM - Free Report) by 40.3% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 945,133 shares of the company's stock after purchasing an additional 271,591 shares during the quarter. Alliancebernstein L.P. owned 0.60% of Tempus AI worth $31,908,000 at the end of the most recent quarter.
A number of other institutional investors and hedge funds have also bought and sold shares of the stock. DnB Asset Management AS purchased a new stake in Tempus AI during the fourth quarter valued at about $641,000. Norges Bank bought a new stake in Tempus AI in the 4th quarter worth approximately $34,681,000. IQ EQ FUND MANAGEMENT IRELAND Ltd boosted its stake in Tempus AI by 429.5% in the fourth quarter. IQ EQ FUND MANAGEMENT IRELAND Ltd now owns 24,133 shares of the company's stock worth $815,000 after buying an additional 19,575 shares in the last quarter. JPMorgan Chase & Co. boosted its stake in Tempus AI by 86,947.2% in the fourth quarter. JPMorgan Chase & Co. now owns 1,653,896 shares of the company's stock worth $55,836,000 after buying an additional 1,651,996 shares in the last quarter. Finally, Mitsubishi UFJ Asset Management Co. Ltd. grew its position in Tempus AI by 255.6% during the fourth quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 67,200 shares of the company's stock valued at $2,269,000 after acquiring an additional 48,300 shares during the last quarter. 24.22% of the stock is owned by hedge funds and other institutional investors.
Wall Street Analyst Weigh In
A number of equities research analysts have recently issued reports on TEM shares. Bank of America upped their price objective on shares of Tempus AI from $54.00 to $60.00 and gave the company a "neutral" rating in a research note on Monday, March 3rd. TD Cowen reiterated a "buy" rating and issued a $74.00 price objective (up previously from $58.00) on shares of Tempus AI in a report on Wednesday, February 5th. Loop Capital reduced their price target on Tempus AI from $57.00 to $52.00 and set a "buy" rating on the stock in a research report on Tuesday, January 14th. Morgan Stanley lifted their price target on Tempus AI from $50.00 to $60.00 and gave the stock an "overweight" rating in a research note on Thursday, March 6th. Finally, Needham & Company LLC reissued a "buy" rating and set a $70.00 price objective on shares of Tempus AI in a research note on Thursday. Six analysts have rated the stock with a hold rating and six have issued a buy rating to the company's stock. Based on data from MarketBeat, the company currently has an average rating of "Moderate Buy" and an average target price of $61.18.
Get Our Latest Stock Report on TEM
Tempus AI Price Performance
Shares of Tempus AI stock traded down $4.00 during trading on Thursday, hitting $39.79. The company's stock had a trading volume of 3,518,706 shares, compared to its average volume of 5,472,862. Tempus AI, Inc. has a 52 week low of $22.89 and a 52 week high of $91.45. The company has a quick ratio of 2.55, a current ratio of 2.69 and a debt-to-equity ratio of 8.17. The company has a fifty day simple moving average of $57.00 and a two-hundred day simple moving average of $51.04.
Insider Buying and Selling at Tempus AI
In other news, CEO Eric P. Lefkofsky sold 3,240,234 shares of the stock in a transaction that occurred on Thursday, February 27th. The shares were sold at an average price of $58.75, for a total transaction of $190,363,747.50. Following the sale, the chief executive officer now owns 4,895,589 shares in the company, valued at $287,615,853.75. This represents a 39.83 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Also, major shareholder Bradley A. Keywell sold 265,000 shares of the company's stock in a transaction that occurred on Friday, January 17th. The shares were sold at an average price of $35.10, for a total value of $9,301,500.00. Following the completion of the transaction, the insider now directly owns 15,218,365 shares in the company, valued at $534,164,611.50. This trade represents a 1.71 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last quarter, insiders sold 5,581,969 shares of company stock valued at $316,538,582.
Tempus AI Company Profile
(
Free Report)
Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.
Featured Articles
Before you consider Tempus AI, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Tempus AI wasn't on the list.
While Tempus AI currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
